The TRX103 Phase 1/2a clinical trial is being led by Maria Grazia Roncarolo, MD, co-founder, president and head of R&D at Tr1X, with patients enrolling at leading stem cell transplant centers across ...

Fibrobiologics' cell therapy CYMS101 significantly increased myelin production and promoted myelin repair in a mouse model of MS ...

Following this FDA approval for the phase 1 clinical trial, the NRI's innovative preclinical work was translated into the clinic with the first patient treated on September 9, 2024. This ...

The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, ...